A start-up company developing nutritional therapies to attack precise molecular cancer targets is raising $47 million in its first venture funding round. . . . → Read More: Cancer Nutrition Therapy Biotech Raises $47M in Early Funds
|
|||||
A start-up company developing nutritional therapies to attack precise molecular cancer targets is raising $47 million in its first venture funding round. . . . → Read More: Cancer Nutrition Therapy Biotech Raises $47M in Early Funds A study is underway testing 3-D printed regenerative breast tissue models, derived from genetically engineered plant cells, implanted in pigs. . . . → Read More: Preclinical 3-D Printed Breast Tissue Implant Study Begins An algorithm designed to analyze microscopic images is shown to largely predict the genetic integrity of embryos from in-vitro fertilization. . . . → Read More: AI Image Analysis Shown to Predict Embryo Health Two developers of tests for infectious diseases are collaborating on a molecular test to detect monkeypox, an emerging international public health concern. . . . → Read More: Diagnostics Companies Partner on Monkeypox Test After a year of nearly constant gains in 2021, venture investments in digital mental health companies took a sharp drop in the first quarter of 2022. . . . → Read More: Infographic – Q1 Mental Health Tech Funds Drop The Food and Drug Administration published its blueprint to encourage new treatments for rare neurodegenerative disorders, including ALS. . . . → Read More: FDA Issues Action Plan for Rare Neuro Diseases We shall discuss the benefits of using the services of experienced engineering consultants in this article. . . . → Read More: An Ultimate Guide to Engineering Consulting Firms A clinical trial has begun testing an influenza vaccine given as a nasal spray with a conventional syringe-delivered vaccine among older U.S. adults. . . . → Read More: Trial Underway of Nasal Spray Flu Vaccine A biotechnology company is licensing a gene-editing enzyme to Novartis to create treatments for inherited blood disorders such as sickle cell disease. . . . → Read More: Biotech in $1.5B Gene-Editing Tech License Deal A new company developing genetic treatments with a high-capacity engineered virus to deliver its therapeutic payloads is raising $38 million in venture funds. . . . → Read More: Gene Therapy Start-Up Gains $38M in Early Funds |
|||||
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |